Skip to Content

Dopram (doxapram) Disease Interactions

There are 4 disease interactions with Dopram (doxapram):


Cns Stimulants (Includes Dopram) ↔ Cardiac Disease

Severe Potential Hazard, Moderate plausibility

Applies to: Pheochromocytoma, Hyperthyroidism, Hypertension, Peripheral Arterial Disease

The use of CNS stimulants is contraindicated in patients with significant cardiovascular impairment such as uncompensated heart failure, severe coronary disease, severe hypertension (including that associated with hyperthyroidism or pheochromocytoma), cardiac structural abnormalities, serious arrhythmias, etc. Sudden death has been reported in adults and children taking CNS stimulant treatment. Additionally, stroke, myocardial infarction, chest pain, syncope, arrhythmias and other symptoms have been reported in adults under treatment. A careful assessment of the cardiovascular status should be done in patients being considered for treatment. This includes family history, physical exam and further cardiac evaluation (EKG and echocardiogram). Patients who develop symptoms should have a detailed cardiac evaluation and if needed, treatment should be suspended.


  1. "Product Information. Dopram (doxapram)." West-Ward Pharmaceutical Corporation, Eatontown, NJ.

Doxapram (Includes Dopram) ↔ Head Injury

Severe Potential Hazard, Moderate plausibility

Applies to: Cerebral Thrombosis/Embolism, Head Injury, Head Injury w/ Intracranial Hemorrhage and Loss of Consciousness

The use of doxapram is contraindicated in patients with head injury, cerebral vascular accident, or cerebral edema. Existing coma may worsen with doxapram administration.


  1. "Product Information. Dopram (doxapram)." West-Ward Pharmaceutical Corporation, Eatontown, NJ.

Doxapram (Includes Dopram) ↔ Reactive Airway Disease

Severe Potential Hazard, Moderate plausibility

Applies to: Pulmonary Impairment, Mechanical Ventilation, Pulmonary Embolism

The use of doxapram is contraindicated in patients with mechanical disorders of ventilation such as mechanical obstruction, muscle paresis, flail chest, pneumothorax, acute bronchial asthma, pulmonary fibrosis or other conditions resulting in restriction of chest wall, muscles of respiration or alveolar expansion. Doxapram is not effective in stimulating respiration in these patients. Doxapram should not be used in patients under mechanical ventilation.


  1. "Product Information. Dopram (doxapram)." West-Ward Pharmaceutical Corporation, Eatontown, NJ.

Cns Stimulants (Includes Dopram) ↔ Renal Dysfunction

Moderate Potential Hazard, Moderate plausibility

Applies to: Renal Dysfunction

Overall CNS stimulants should be administered with caution in patients with significantly impaired renal function as the reduction in the rate of elimination may alter the therapeutic response. The dosage should be adjusted accordingly.


  1. "Product Information. Provigil (modafinil)." Cephalon, Inc, West Chester, PA.

Dopram (doxapram) drug Interactions

There are 332 drug interactions with Dopram (doxapram)

Dopram (doxapram) alcohol/food Interactions

There is 1 alcohol/food interaction with Dopram (doxapram)

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. Multum's information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill, knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2018 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.